Patanol and Altace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Patanol (olopatadine hydrochloride) and Altace (ramipril). Common drug interactions include blood pressure decreased among females and blood cholesterol increased among males.

The phase IV clinical study analyzes what interactions people have when they take Patanol and Altace. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Patanol?

Patanol has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 5,339 Patanol users. Check the latest studies of Patanol.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.



On Jul, 14, 2026

37 people who take Patanol and Altace together, and have interactions are studied.

Patanol and Altace drug interactions.

What are the common drug interactions of Patanol and Altace, by gender? *:

female:

  1. Blood pressure decreased
  2. Blood triglycerides increased
  3. Catheter related infection
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  5. Cough
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Diarrhoea
  8. Dry mouth
  9. Dyspepsia (indigestion)
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Blood cholesterol increased
  2. Depression
  3. Blood glucose decreased
  4. Cardiac arrest
  5. Cardiac disorder
  6. Cardiac failure congestive
  7. Cardiogenic shock (inadequate circulation of blood)
  8. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  9. Chest pain
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Patanol and Altace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)
  2. Arrhythmia (irregular heartbeat)
  3. Arteriosclerosis (thickening and hardening of arteries)
  4. Blood glucose decreased
  5. Fall
  6. Hypoglycaemic unconsciousness (unconsciousness due to low blood sugar)
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Swelling face
  9. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  10. Weight decreased

50-59:

  1. Malignant hypertension (a hypertensive emergency is a condition in which elevated blood pressure results in target organ damage)
  2. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Retinal disorder (disease of retina)
  7. Skin disorder (skin disease)
  8. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  9. Visual disturbance
  10. Angina pectoris (chest pain due to ischemia of the heart muscle)

60+:

  1. Blood cholesterol increased
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Joint swelling
  4. Lung disorder (lung disease)
  5. Muscle spasms (muscle contraction)
  6. Oedema peripheral (superficial swelling)
  7. Pain
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Poor venous access

What are the existing conditions these people have? *

  1. Diabetes: 12 people, 32.43%
  2. High Blood Cholesterol: 12 people, 32.43%
  3. Hypersensitivity: 10 people, 27.03%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 24.32%
  5. Rosacea (a skin condition that causes facial redness): 9 people, 24.32%
  6. Pain: 7 people, 18.92%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.11%
  8. Nerve Injury: 3 people, 8.11%
  9. Multiple Allergies (allergy to multiple agents): 3 people, 8.11%
  10. Cardiac Disorder: 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Patanol and Altace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Patanol and Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Patanol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Patanol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Altace and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on olopatadine hydrochloride and ramipril (the active ingredients of Patanol and Altace, respectively), and Patanol and Altace (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: